PHATHOM PHARMACEUTICALS INC. - COMMON STOCK

Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032

06 6 2025 09:27:43 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

15 5 2025 04:59:54 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 5 2025 13:15:59 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

01 5 2025 04:00:41 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting

28 4 2025 04:59:05 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025

23 4 2025 05:00:22 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

16 4 2025 05:00:46 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

03 4 2025 05:00:25 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 4 2025 13:15:41 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Leadership Succession

01 4 2025 05:00:58 提供 Nasdaq GlobeNewswire

Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan)

31 3 2025 04:59:26 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

06 3 2025 05:00:01 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025

24 2 2025 05:00:50 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference

29 1 2025 05:00:33 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets

11 12 2024 05:00:00 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates

07 11 2024 05:00:01 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

04 11 2024 05:00:14 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024

28 10 2024 05:00:49 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting

27 10 2024 09:00:40 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

29 8 2024 05:00:43 提供 Nasdaq GlobeNewswire